We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Adamas Pharmaceuticals Inc | NASDAQ:ADMS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.22 | 9.33 | 8.30 | 0 | 01:00:00 |
|
|
|
|
|
Delaware
|
|
001-36399
|
|
42-1560076
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
of incorporation)
|
|
|
|
|
1900 Powell Street, Suite 750
Emeryville, CA
|
|
94608
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
Exhibit No.
|
|
Description
|
|
99.1 Press Release dated February 22, 2018.
|
|
|
Adamas Pharmaceuticals, Inc.
|
|
|
|
|
|
Dated:
|
February 22, 2018
|
By:
|
/s/ Alfred G. Merriweather
|
|
|
|
Alfred G. Merriweather
|
|
|
|
Chief Financial Officer
|
1 Year Adamas Pharmaceuticals Chart |
1 Month Adamas Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions